Glutamine Synthetase1 (GS1) is an enzyme that catalyzes the ATP-dependent synthesis of Lglutamine from L-glutamate and ammonia as a key element of the glutamate glutamine cycle, a complex physiological process occurring between glia and neurons, necessary to control the homeostasis of glutamate. Using a Drosophila model for Huntington's disease, we report that expression of GS1 in neurons ameliorates the motility defects of animals expressing the mutant Httex1-Q93 form of the huntingtin gene. At the cellular level, expression of GS1 increases the basal level of autophagy and significantly reduces the size of the toxic Htt-Q93 protein aggregates. In addition, we found that expression of GS1 prevents TOR localization at the lysosomal membrane and reduction in the phosphorylation of its effector S6K. This study reveals a novel function for GS1 in neurons linking its activity to the inhibition of TOR signaling and autophagy. The identification of novel pharmacological regulators of autophagy is of particular interest considering its beneficial role in controlling neuronal health and counteracting the detrimental effects of toxic aggregates of proteinopathies including Huntington's disease.
Introduction
Many efforts have been focused to develop therapies to improve neuronal health, particularly those that promote autophagy, a self-cleaning process known to improve the symptoms of neurodegenerative disorders (NDDs) [1] , especially for proteinopathies such as Huntington's disease (HD) where autophagy favors the clearance of the toxic protein aggregates [2] . HD is an inherited adult-onset neurodegenerative disease characterized by the presence of an abnormal long sequence of CAG repeats in the first exon of the huntingtin gene (HTT, Chr. 4p16.3 MIM 143100), encoding a protein with a non-physiological long poly-Q trait at the N-terminus [3, 4] . HD is characterized by the progressive degeneration of neurons in the striatum and cortex. This results in motor defects, cognitive decline and death. The age of clinical onset in HD is highly variable (with a mean of ~45 years), but is strongly influenced by the length of the CAG trinucleotide expansion within the HTT gene. Although many cellular and molecular mechanisms are identified in HD, at present, there are no effective therapies [5, 6] , and one emerging strategy to ameliorate HD is the inhibition of the TOR signaling pathway which then allows the induction of autophagy [7] .
Neuronal health is also controlled by a non-autonomous cycle, called Glutamate-Glutamine Cycle (GGC) that is responsible for the exchange of glutamine and glutamate between glia and neurons thus mantaining their concentration at physiological levels [8] . Among the key enzymes controlling 4 the pool of amino acids that are reduced. In addition, we found an opposite regulation of aspartate with respect to asparagine, which increases in the presence of GS1 suggesting an up-regulation of the activity of the enzyme asparagine synthetase (ASNS) that converts aspartate into asparagine from glutamate with the use of glutamine. Interestingly, ASNS was shown to be necessary for the regulation of the uptake of amino acids, especially serine, arginine and histidine, essential for the survival of tumor cells [26, 27] . Overall, our data suggest that the expression of GS1 in neurons results in a reduction of essential amino acids that in turn results in autophagy. Glutamine levels are not reduced but perhaps used, together with aspartic acid, in asparagine catabolism, to constitute a feedback loop that maintain autophagy active and favors cellular survival. In conclusion, we show a novel role for GS1 that induces autophagy and reduces the formation of Htt-Q93 toxic aggregates to ameliorate the motility defects in a Drosophila model for HD. Understanding the mechanisms that link the metabolic pathways activated by GS1 to amino acids signaling in neurons, would be an initial step to delineate a novel function for this enzyme, part of the GGC, in the brain necessary to control autophagy and to induce neuronal survival not only in pathological situations such as HD but also in physiological conditions during neuronal homeostasis and in ageing.
Results

GS1 rescues neuronal death induced by expression of Httex1-Q93 in the retina.
GS1 expression was found reduced in post-mortem brains from HD patients [14] [15] [16] [17] . In addition, human fibroblasts from HD patients have increased levels of glutamate that correlate with (CAG) n length in the HTT gene (Fig. 1A) . Since GS1 converts glutamate into glutamine, we investigated whether overexpression of Drosophila GS1 in neurons could reduce glutamate concentration and ameliorate the pathological effect of mutant Htt (mHtt) in a Drosophila model for HD generated by expressing Httex1-Q93. This model was shown to recapitulate many of the cellular and molecular events described in neurons of human HD patients including motility defects [28] . In Drosophila, two distinct genes (GS1 and GS2) encode glutamine synthetase [12] . GS1 (Fig. 1B) is 70.5% homologous to human GLUL/GS1 [11] (Supplementary Fig. 1A ) and is the prevalent form expressed in neurons [12] . Expression of GS1 in vivo, using the ubiquitous actin-Gal4 promoter, results in the production of a GS1 mRNA ( Supplementary Fig. 1B ) encoding a 50 kDa protein (Fig. 1C ) which correlates with a specific increase of GS1 enzyme activity (Fig. 1D ). We first analyzed in the retina, using the tissue-specific GMR-Gal4 promoter, whether co-expression of GS1 and Httex1-Q93 was able to reduce neuronal degeneration of eye pigment cells, as previously shown in the Httex1-Q93 HD model [28, 29] . In our experiments, co-expression of GS1 5 and Httex1-Q93 completely rescued the lack of pigmentation in the ommatidia induced in neuronal cells by Httex1-Q93 expression (compare Fig. 1F with 1G). Expression of GS1 alone did not alter eye morphology and pigmentation was similar to that of control Httex1-Q16 animals (Figs. 1H and 1E). On the contrary, reduction of GS1 using RNA interference (RNAi) exacerbated the defects in the ommatidia of animals expressing Httex1-Q93 and these animals showed premature loss of pigment cells that at 8 days after eclosion (DAE) was similar to that of animals expressing Httex1-Q93 at 20 DAE (Supplementary Fig. 2A) . A detailed ultramicroscopic analysis of the tissues underneath the ommatidia from flies expressing Httex1-Q93 showed a remarkable alteration of cornea morphology with the presence of large vacuoles indicating loss of the cells underneath the retina (Fig. 1J) . Expression of GS1 ameliorates this phenotype and also restricted cell death to a small area beneath the cornea (Fig. 1K ). Morphological analysis of the retina from GS1 and control
Httex1-Q16 animals revealed no defects ( Fig. 1L and I, respectively).
Neuronal degeneration can be analyzed by measuring the decay over time of the intensity of GFP expressed in cells of the retina [29] . GFP was expressed in the retina together with our transgenes and GFP intensity analyzed (Fig. 1M) . These experiments showed that expression of Httex1-Q93
significantly decreases GFP fluorescence in the ommatidia quantified at 20 DAE (ANOVA P<0.0001) (Fig. 1N) . Moreover, co-expression of GS1 completely rescued this defect supporting the hypothesis that GS1 activity counteracts neuronal death induced by Httex1-Q93 expression in the retina cells. GFP intensity in control GMR-Q16 and GS1 animals ( Fig. 1N) was not significantly different (ANOVA P=ns). (ANOVA data-analysis is in the supplementary Excel file).
GS1 expression in neurons improves locomotion defects of Httex1-Q93 animals.
To analyze if the ability of GS1 to rescue neuronal degeneration in the retina was extended to neurons controlling animal motility, we co-expressed GS1 and Httex1-Q93 using the elav c155 -Gal4 pan-neuronal promoter, hereon referred to as elav-Gal4 [28] . Analysis in larval brains for proper expression of the transgenes showed that Httex1-Q16 and Httex1-Q93 encode a 35 kDa and a 55 kDa protein, respectively. Expression of Httex1-Q93 also results in the formation of high-molecularweight bands (HMW-mHtt) entrapped in the stacking gel and visible also in brains co-expressing
Httex1-Q93 and GS1 ( Fig. 2A) . The presence of these high molecular weight forms reacting with the anti-Htt antibody is a characteristic pattern of expression for the mutant Htt, as previously showed in Drosophila heads expressing the same Httex1-Q93 transgene [29, 30] .
Since one hallmark of HD is a progressive impairment in the movement [28] , we investigated whether expression of GS1 could rescue animal motility defects induced by Httex1-Q93 expression in neurons. We first analyzed differences in larval motility by comparing the ability of third instar 6 animals to crawl in an arena ( Supplementary Fig. 3C-E, movies) . These experiments showed that the motility defects induced by Httex1-Q93, visible already at 48-72 hours after egg laying (AEL) (Fig.   2B , ANOVA P<0.0001), are completely rescued by co-expression of GS1 (ANOVA P=ns). Adults
Httex1-Q93 hatched at the expected developmental time without any visible morphological defects but with a 30% of lethality at the stage of pharates (Fig. 2C ). Co-expression of GS1 completely rescued also the hatching defects, while animals expressing GS1 alone did not show any visible defect in motility (Fig 2B, ANOVA ns) , and have a survival rate similar to control Httex1-Q16 ( Fig   2C) . In adult animals, western blot analysis using lysates from the heads of females at 8 DAE show a pattern of expression for Htt-Q16 and Htt-Q93 proteins similar to that of the larval brains (Fig. 2D ).
GS1 protein levels and enzyme activity were similar in the heads of flies expressing GS1 alone or coexpressing Httex1-Q93 (Fig. 2E) . Moreover, GS1 enzyme activity was inhibited with the same efficiency in both genotypes by the specific GS1 inhibitor methionine sulfoximine (MSO) ( Supplementary Fig. 4 ). To analyze if co-expression of GS1 ameliorates the motility defects of adult flies, we performed climbing assays over a period of time ( Supplementary Fig. 3F were confirmed using three independent Httex1-Q93, GS1 recombinant lines ( Supplementary Fig. 5 ).
Motility reduction is often accompanied by a decrease in the survival rate of the animals (Fig. 2H ).
Expression of GS1 was also able to reduce lethality of elav/+; Httex1-Q93/+ flies (Fig. 2H , ANOVA P<0.05), while flies expressing GS1 alone and control Httex1-Q16 did not show any visible alterations in their motility or viability.
In males, expression of Httex1-Q93 revealed a very low survival rate and elav/Y; Httex1-Q93/+ animals have defects in climbing activity that was 50% reduced at about 2-3 DAE (Supplementary Fig. 6A-B) . The stronger effect of Httex1-Q93 in males is probably due to a dosage compensation effect since the elav-Gal4 transgene is inserted in the X chromosome [31] .
To estimate the rescue of neuronal death by GS1, we analyzed the expression of neural markers in lysates from the heads of females at 8 DAE. These experiments showed that co-expression of GS1 rescues the reduction of elav and synapsin protein levels, detected in cell extracts from 7 animals expressing Httex1-Q93 alone (Fig. 2I) , suggesting that the activity of GS1 rescues neuronal death in the adult heads.
Expression of GS1 reduces Htt-Q93 protein aggregates in neurons.
Mutant Htt forms large toxic intracellular aggregates. Expression of Httex1-Q93 using the elav promoter results in large protein aggregates clearly visible by immunofluorescence in the gigantic cells of Drosophila larval salivary glands (Fig. 3A) where the elav-Gal4 promoter is also transcriptionally active. Since co-expression of GS1 restored the motility defects of Httex1-Q93 (Fig. 3M ).
Altogether, our data suggest that GS1 induces a mechanism that helps or favors the degradation of the toxic mHtt-Q93.
GS1 induces autophagy in neurons expressing Httex1-Q93.
In neurons, one of the major pathway for the clearance of toxic aggregates is the autophagylysosomal system [32] . To investigate whether GS1 may activate an autophagy-lysosomal pathway in neurons, which may explain the reduction of Htt-Q93 aggregates, we analyzed the formation of the characteristic autophagosome vesicles in vivo using the reporter mCherry-Atg8a. This construct expresses the autophagosome-associated ubiquitin-like protein Atg8a fused with the fluorescent mCherry protein allowing the visualization of autophagosomes as fluorescent punctae/vesicles visible under fluorescence microscope [33] . To identify neurons, we co-expressed mGFP under the control of the elav-Gal4 promoter (Fig. 4C) . Quantification of the intensity of fluorescence of mCherry-Atg8a in the autophagosome, was analyzed in the region of the calyx (Fig. 4A , B, and D) 8 and in the Ventral Neuronal Cord (VNC) (Fig. 4C-E We then analyzed if the ability of GS1 to ameliorate motility in Httex1-Q93 animals was dependent on a functional autophagic pathway by genetically reducing the expression of Atg1/ULk1 or Atg5, key components of macroautophagy, using RNAi lines [34] . These experiments showed that reducing either Atg1 or Atg5 completely abolished the ability of GS1 to ameliorate the climbing defects in Httex1-Q93; GS1 animals ( Fig. 4H ) (One-way-ANOVA data-analysis are in supplementary Excel file), confirming our hypothesis that the ability of GS1 to ameliorate the motility defects in HD animals depends on an active autophagic pathway. In autophagy, the size of the autophagosome is regulated by the amount of Atg8a protein recruited to the vesicles during maturation of the phagosome, and by the presence of the p62/SQSTM1 (sequestosome 1), which recruits ubiquitinated substrates to the autophagosomes, features conserved also in Drosophila [35] .
In the autophagosome, the Atg8a protein (15 kDa Atg8a-II form (2.7-fold) and a similar effect was observed when GS1 was co-expressed with Httex1-Q93 (2.1-fold) (Fig. 4I) . Moreover, analysis of p62 expression revealed a reduction in the heads of Httex1-Q93 animals co-expressing GS1 (0.25-fold) compared to control Httex1-Q16, and a similar decrease was observed in animals expressing GS1 alone (0.35-fold) (Fig. 4I ). Altogether, these data suggest that GS1 activity induces an active autophagic flux also in neurons from animals carrying mHtt.
Expression of GS1 reduces S6K phosphorylation and TOR localization at the lysosomal 9 membrane.
Autophagy is inhibited by the presence of essential amino acids that stimulate TOR kinase to translocate into the lysosomal membrane and to be assembled into the TORC1 complex, resulting in its activation and phosphorylation of downstream signaling targets, including S6K and 4EBP [36] .
To explore the ability of GS1 to affect TOR signaling, we analyzed the level of phosphorylation of S6K on Thr-398 in lysates from the heads of adult animals. This analysis revealed that expression of GS1 in neurons reduces the levels of S6K phosphorylation (ratio 0.42/1.00, p<0.05) (Fig. 5A ), a condition that is conserved also when GS1 is co-expressed with Httex1-Q93 (ratio 0.76/1.00,
p<0.05).
To analyze whether the reduction of S6K phosphorylation was due to an impairment of TOR translocation to the lysosome, we analyzed its co-localization with the lysosome membrane marker LAMP1-GFP. TOR kinase was visualized by immunofluorescence using an antibody against human TOR, which also recognizes the Drosophila orthologue ( Fig. 5B , and Supplementary Fig. 8 ).
This analysis showed that TOR localization was significantly reduced in lysosomes from neurons expressing GS1 compared to that in neurons from control Httex1-Q16 animals, where is normalized to 1 (Fig. 5C , compare brown to black lanes, Student t-test, p<0.05). This reduction was maintained also in animals co-expressing GS1 and Httex1-Q93 (Fig. 5C , compare purple to black lanes, p<0.01).
Moreover, a significant reduction in TOR localization was detected in the lysosome from neurons of animals co-expressing GS1 with Httex1-Q93 (Fig. 5C , compare purple to red lanes, Student t-test, p<0.05) indicating that GS1 activity is able to induce a mechanism that inhibits the displacement of TOR from the lysosome membrane also in HD animals.
Expression of GS1 in neurons increases glutamine levels
Similar to our data in fibroblasts from HD patients (Fig. 1A To identify significant changes in the pattern of amino acid levels modulated by GS1 expression, we analyzed the profile of Essential (EAA) and Non Essential (NEAA) amino acids in the lysates from heads of flies expressing GS1 in neurons and compared it to that from control Httex1-Q16 (Fig. 6B ).
This analysis confirmed that glutamine (Gln), and alanine (Ala) and methionine (Met) as well, was significantly increased upon GS1 expression (p<0.001), while EAA such as isoleucine (Ile) and histidine (His), and NEAA such as proline (Pro) and arginine (Arg) were significantly reduced. Of particular interest was the decrease in the concentration of aspartic acid (Asp) that was accompanied by an increase of asparagine (Asn). This last set of data may suggest the activation in neurons of asparagine synthetase (ASNS), the enzyme that hydrolyzes glutamine to produce asparagine from aspartic acid and glutamate. ASNS is usually elevated in tumor cells to induce cell survival upon nutrient deprivation by switching to the endogenous production of asparagine [27] .
Fibroblasts from patients with Huntington's disease have decreased autophagy and reduced level of GS1.
Since autophagy was found to be defective in HD [37, 38], we analyzed fibroblasts derived from patients expressing the mutant huntingtin gene to establish whether the autophagic flux was compromised also in these cells. The amount of cleaved LC3, the human homolog of Atg8a, was determined by immunoblot in fibroblasts from HD patients and control donors. This analysis showed that fibroblasts from HD patients exhibit a reduction of the fast migrating band corresponding to the cleaved LC3-II form as compared to that in control fibroblasts (Fig. 7A, upper gel) . A similar result was obtained using anti-Atg8a antibodies (Fig. 7A , middle gel). Since GS1 expression was decreased in post-mortem brains from HD patients, we also analyzed its expression and found that GS1 protein is reduced by 43 % in HD fibroblasts (Fig. 7B) . Huntingtin is present in both these lines as a band of about 350 kDa; in addition, a band of about 80kDa is detected only in the lysates from HD patients carrying 78-90 CAG repeats in the HTT gene (Fig. 7C ). Taken together, these results suggest that in fibroblasts carrying mutant huntingtin the autophagic flux is compromised and the levels of GS1 are partially reduced. This observation fully supports our observation that GS1 plays an important role in controlling the autophagic flux in wild-type cells, but also that its expression may be compromised in pathological conditions, such as HD, which affect the physiological role of autophagy necessary to keep cells, and in particular neurons, in healthy conditions.
The glutamate-glutamine cycle (GGC) is a sequence of biochemical events between neurons and glia cells necessary for the control of glutamate homeostasis. Previous studies showed that this cycle is impaired in mouse and Drosophila models for HD [39, 40] . In addition, the activity of Glutamine Synthetase-1 (GS1), a key regulator of the GGC, was found to be reduced in post mortem brains of HD patients [14, 41] . To elucidate the role of GS1 in HD, we modulated its activity in neurons using a Drosophila model expressing the mutated human exon1 Httex1-Q93 that mimics many aspects of neurodegeneration induced by toxic polyglutamine expansion in HD patients [28] . Our data show that neuronal expression of the Drosophila homolog of human GS1 ameliorates animal motility and reduces neuronal death induced by expression of Httex1-Q93. Moreover, we found that coexpressing GS1 with Httex1-Q93 reduces the size of the toxic HttQ93 aggregates and increases the levels of macro-autophagy, herein referred to as autophagy, establishing a novel link between the GGC and functional autophagy in post-mitotic cells.
Autophagy is an evolutionarily conserved mechanism that mediates the degradation of cellular debris through the action of lysosomes and has an established positive role in several processes beneficial for neurons under both normal and pathological conditions [1, 42] . Autophagy is activated by the action of specific autophagy-related genes (ATGs) genes, whose function is highly conserved both in flies and vertebrates [43] . Atg1, the Drosophila homolog of mammalian ULK1 kinase, forms the first initiation complex (consisting of the kinase Atg1/ULK1, Atg13, and Atg17) and its activity is inhibited by phosphorylation of TOR kinase [44] . As the process continues, Atg5, which operates downstream in the cascade, becomes involved together with Atg8 in vesicle elongation during the autophagosome maturation. This step is important as lipidation of Atg8 and its proteolytic cleavage are used as readouts of an active autophagic flux in western blots. The autophagosome eventually matures into a closed cargo-containing vesicle, which then fuses with the lysosome to become the autolysosome, where the cargo is degraded for recycling. The latter step is carried out by the protein p62/SQSTM1 or sequestosome-1 that is then degraded by ubiquitination [45] . Recently, a physiological role for the wild-type Htt protein was assigned in controlling the initial steps of the autophagosome formation and the recognition of p62 in the cargo formation [46, 47] . Furthermore, the proteolytic stress induced by mutant Htt (mHtt) was shown to favor the interaction of p62/SQSTM1 with ULK1 to regulate the clearance of toxic aggregates [48] . p62 also when Httex1-Q93 is co-expressed, suggesting that its activity favors cargo degradation and the autophagic flux.
The important role of autophagy in neurons is revealed by reducing ATGs genes, since conditional knock-out of ATG5 and ATG7 in neurons results in progressive motoneuron defects, alteration in autophagosome formation and accumulation of ubiquitin-positive protein aggregates in degenerating neurons [50] [51] [52] . These phenotypes are conserved in Drosophila where atg7 D77 mutants have a short life-span, reduced motility, and accumulation of ubiquitinated proteins [53] . Lack of ULK1/ATG1 in mice causes defects in the endocytosis process and abnormal axonal branching, a function conserved also in C. elegans and Drosophila [54, 55] . Moreover, polymorphisms in the ATG genes, including ATG5, and ATG7, have been associated with early onset of NDDs, including HD [56] , evidencing the protective role of physiological autophagy also in humans. In our experiments, we found that reducing the expression of atg1 and atg5 in neurons of animals expressing Httex1-Q93 significantly exacerbates the motor degeneration phenotype induced by mHtt, while the rescue driven by GS1 overexpression was completely abolished, further confirming that GS1 function requires a functional autophagic pathway to exert its activity in neurons.
Autophagy is inhibited by nutrients and amino acids that are normally required for TOR activation and translocation to the lysosomal membrane [7, 57] . Our data show that expression of GS1 impairs TOR localization in the lysosome. Such data are supported by the reduction of S6K phosphorylation that was clearly visible in lysates from the heads of animals both expressing GS1 alone and coexpressing GS1 and Httex1-Q93. GS1 converts glutamate into glutamine, and analysis of the levels of these two amino acids in the heads of animals expressing GS1, showed that glutamate was reduced in Httex1-Q93, GS1 animals where we rather observed a significant increase in glutamine.
TOR signaling controls cell growth and protein synthesis in response to nutrients and amino acids.
However, its activation depends on the cellular milieu and functions through a mechanism that is mostly conserved from yeast to mammals [58] . In general, amino acid stimulation of TORC1 at the lysosome membrane depends on the activation of the Rag guanosine triphosphatases (GTPases), the Ragulator complex, and the vacuolar H + adenosine triphosphatase (v-ATPase) [59] . However, the ability of single amino acids to control TOR activity seems to be controlled specifically by certain branches of the pathway [60] . Recently, many studies on the ability of 1 3 different amino acids to stimulate TOR signaling have been focused on the specificity of glutamine [61, 62] , leucine [20, 36, 61] , and arginine [63] .
For example, glutamine, which is a nonessential amino acid synthesized by glutamine synthetase, has been shown to bind or activate the adenosine diphosphate ribosylation factor-1 GTPase (Arf1) to directly activate TORC1 at the lysosome membrane, and in epithelial cells, glutamine requires the function of the v-ATPase to fully activate TORC1 [60] . In addition, glutamine can be used indirectly to stimulate TORC1 via glutaminolysis, where glutamine is first converted into glutamate by GLS (glutaminase). GDH (glutamate dehydrogenase) then converts glutamate into α -ketoglutarate to directly activate TORC1 [64] or to participate in the anaplerotic reactions of the tricarboxylic acid cycle when nutrients are reduced [65, 66] .
Because of its involvement in a multiplicity of metabolic pathways, the function of glutamine in the activation of TOR signaling still presents some controversial results. Glutamine has been shown mainly to activate TORC1 directly or by a positive feed-back loop controlled by autophagy that increases the pool of amino acids, including glutamine and arginine to re-activate the TOR pathway [67] . Our data in neurons show that TOR signaling is reduced by expression of GS1 (low level of Glutamine is utilized by the cells also to control the import of essential amino acids (EAAs). Indeed, a distinct mechanism described so far in epithelial cells, links leucine and EAAs to the glutamine flux [61] . Through this mechanism, glutamine imported in the cytoplasm by the SLC1A5 transporter is exported by the heterodimeric anti-porter system (SLC7A5-SLC3A2) to import leucine and ultimately stimulate TORC1 [69] . Moreover, since our amino acid analysis from the heads of animals expressing GS1 in neurons shows an increase in glutamine levels we can speculate that the system that controls the export of glutamine is impaired, and consequently this may reduce the import of EAAs such as isoleucine (Ile) and histidine (His) resulting in the inhibition of TOR signaling.
Expression of GS1 also reduces the level of glutamate in favor of glutamine. Glutamate is a nonessential amino acid that function as an excitatory neurotransmitter in the central nervous system and 1 4 as a substrate in many distinct reactions [70] . Glutamate is synthesized from glutamine, α -ketoglutarate and 5-oxoproline and it serves as a precursor molecule for the biosynthesis of various amino acids including proline (Pro) and arginine (Arg) [65, 66] . Interestingly, in the heads of animals expressing GS1, we found a significant reduction of Pro and Arg, both relevant in the mechanism of TOR activation through specific amino acid sensors [59] . In particular, the lysosomal amino acid transporter SLC38A9, proposed in mammals to function upstream of TORC1 [26] , was found necessary for TOR activation by Arg, while its constitutive expression renders the cells insensitive to the stimulation by amino acids, including arginine [63] . So far there are no data describing the mechanism of activation by SLC38A9 in neurons. However, since we found that Arg levels are reduced in the heads of elav>GS1 animals, we hypothesize that in neurons Arg is required for the activation of TOR by SLC38A9. Moreover, these data may also suggest that in neurons activation of SLC38A9 by Arg acts downstream of glutamine in the activation of the TOR pathway since glutamine is not a limit. It is worthy to note that, although the Drosophila SLC38A9 transporter has not been characterized yet, the Drosophila genome contains three genes expressed in the brain (CG13743, CG30394, and CG320181) [71] [72] [73] , whose sequences are significantly homologous to that of human SLC38A9 [74] , suggesting that they may encode the fly functional homolog(s) of SLC38A9.
Another mechanism that cells use to counteract the decrease of glutamate levels, is to convert the excess of glutamine into asparagine through the enzyme asparagine synthetase (ASNS), which converts aspartate (Asp) and glutamine to asparagine (Asn) and glutamate (Glu). By looking at the concentration of those amino acids in the heads of animals expressing GS1, we also found that Asn concentration was significantly increased while, on the contrary, Asp decreased. This would indicate an upregulation of the activity of ASNS, an enzyme that is induced in tumor cells during nutrient starvation [26, 27, 75] . This may suggest that ASNS in neurons responds to amino acid starvation induced by GS1 by increasing the levels of Asn and Glu, which is also in the substrate of GS1. In support to this hypothesis, we found that upon GS1 expression Glu levels are only slightly reduced, while the concentration of few other amino acids, such as isoleucine, phenylalanine, histidine, proline, and serine, that are necessary to TOR activation are significantly lower. Alanine levels instead increased, possibly because of the rise in glutamine that indirectly participates in glutamate synthesis via glutaminolysis, or to support metabolic pathways in the biosynthesis of proteins [76] .
Conclusion:
Our data show a novel function for GS1 in controlling autophagy in neurons to ameliorate the 1 5 detrimental effect of the accumulation of toxic Htt aggregates. Neurons differ from other cell types for being post-mitotic and highly dependent on the endo-lysosomal pathway for active signaling in axons and dendrites. Therefore, these cells particularly require effective protein degradation as a quality control mechanism for cell survival. Any alteration of this process, especially under disease conditions, causes the accumulation of abnormal proteins, leading to cellular toxicity and ultimately neurodegeneration. Malfunctions in components of the glutamate-glutamine cycle have been detected in many neurodegenerative diseases including Parkinson, Alzheimer and Huntington [14, 77, 78] . Significant progress has been made to understand the nature of both ageing and neurodegeneration, and the impairment of autophagy is one of the major risk and possible cause of numerous NDDs that are diagnosed in elderly when the physiological role of autophagy starts to decline. Here, we were able to find a novel function for GS1, a key enzyme that controls glutamate homeostasis, in the regulation of autophagy in neuron [79] . Moreover, our observations in fibroblasts from HD patients suggest that the link between GS1 activity and autophagy is conserved in humans as well, thereby paving the way for future research on the role of GS1 in autophagy and in potential HD therapeutic targets using HD Drosophila models.
Materials and Methods
Fly husbandry and lines
Animals were raised at low density, at 25°C, on a standard food medium containing 9 g/L agar (ZN5 
Survival at eclosure analysis
The number of animals and their timing of eclosion from every cross with the elav-Gal4 C155 driver were quantified and the percentage of animals eclosed was calculated for each of the genotypes of interest with respect to the expected number of animals that eclosed.
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Motility assays
The motility assay with larvae was performed with ten 3 rd instar animals for each genotype of interest. Larvae were collected, washed with PBS and then transferred to a 14 cm Petri dish containing 1% agarose in PBS where a visible grid was drawn (Supplementary Fig. 3 ). The number of lines crossed by one larva in 1 minute at room temperature was counted. Statistical analysis was performed with the Student's t-test; values for each genotype are represented as mean ± standard deviation (SD). Experiments were repeated at least three times. For motility assays with adult animals, one day-old females of each genotype were transferred in a plastic vial without food (15 animals for each genotype), and their ability to climb up the empty vial after a knock-down to the bottom was analyzed, as previously described [80] . 
Quantification of fluorescence (GFP) on the adult compound eye
Photographs of adult eyes expressing the indicated UAS-transgenes in the retina and co-expressing UAS-GFP using the GMR-Gal4 promoter, were taken at 8 days after eclosion using a Leica stereomicroscope MZ10F with a fluorescent source and a camera, using 5x magnification. The intensity of fluorescence in each image was quantified as integrated density from an area containing 20 ommatidia using Adobe Photoshop-CS4 and expressed as GFP intensity/area,. At least 10 eyes (one for each animal) were used for each genotype and experiments were repeated twice.
Western blot
Proteins were extracted from ten brains of larvae or 10 adult heads collected in lysis buffer (50 mM Hepes/NaOH pH 7.4, 250 mM NaCl, 1 mM EDTA, 1.5% Triton X-100 containing phosphatases and proteases inhibitors (Roche). For detection of the Huntingtin protein, lysates were extracted using 2% SDS lysis buffer (50 mM Hepes/NaOH pH 7.4, 250 mM NaCl, 1 mM EDTA, 2% SDS containing phosphatases and proteases inhibitors. Samples were sonicated three times for 10 seconds (1:500 Thermo Fisher #OSA00026W).
Filter trap assay
Ten larval brains or adult heads for each genotype were homogenized in lysis buffer (50 mM TrisHCl pH 6.8, 2% SDS plus proteases and phosphatases inhibitors). Fifty micrograms of protein extracts were loaded on a dot-blot device and filtered through cellulose acetate membrane (0.22 µm pore size), previously washed in 1% (w/v) SDS solution in PBS. After filtration, membranes were washed three times in TBS-T, saturated in 5% non-fat milk and processed for immunodetection with anti Htt antibodies from Abcam, as described above.
Patient-derived cell lines
Each individual providing a biological sample signed written informed consent approved by the Institutional Review Board of the Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy, in agreement with the Declaration of Helsinki. Fibroblasts from patient and controls were grown in the DMEM-high glucose or -galactose media as described previously in [86] .
MS/HPLC for glutamate and glutamine quantification and analysis of amino acids
10 heads from animals at 8 DAE were resuspended in 100 μl of Hepes/NaOH 50mM with proteases and phosphatases inhibitors (Roche), samples were disrupted using a mechanical tip following two 
Quantification of GS1 activity
Drosophila larvae or heads that had been flash frozen in liquid nitrogen were resuspended in 200 µl 50 mM Hepes/NaOH buffer, pH 7.4 and 0.5% protease inhibitors cocktail (Sigma P8849). They were homogenized with a Branson 250 sonifier equipped with a microtip (25% power, 20% duty cycle) by applying four series of 10 sonication pulses and controlling the temperature by immersion in an ice bath. The homogenate was centrifuged in a microfuge at 13000 rpm for 30 min at 4°C and passed through a Ultrafree-MC (Millipore UFC306V) filter device by centrifuging at 11000 rpm for 15 min at 4°C. The filtrate was used for protein and activity assays. Protein concentration was determined with the Bradford method and bovine serum albumin as the reference protein [81] .GS activity was assayed by quantifying the amount γ -glutamylhydroxyamate (GGHA) produced as described in [82] [83] [84] . In preliminary experiments a range of GGHA concentrations (0.07-0.15 mM) was used to determine the sensitivity and linear range of the assay. Briefly, a known amount of crude extract The amount of GGHA produced was calculated from the absorbance value at 500 nm and 600 nm with a HP 8453 diode array spectrophotometer using the reported extinction coefficients of 1.004 mM -1 cm -1 and 0.471 mM -1 cm -1 [82] for the crude extracts derived from larvae and heads, respectively; by monitoring the entire spectrum of the final solution, we ensured that no artifacts 1 9 arose from turbidity, precipitation or presence of pigments, especially with Drosophila heads. For each assay a blank devoid of L-Glu and ATP was set up and the measured absorbance was subtracted to that of the corresponding sample prior to calculation of the activity value. The amount of larvae or heads extracts were selected in order to ensure that GGHA concentration increase was linear with respect to the incubation time. L-Methionine sulfoxide (MSO) was added to reaction mixtures at a final concentration of 1 mM (from 10 mM stock solution in 50 mM Hepes/NaOH buffer, pH 7.4) to test its effect on GS1 activity. Activity was expressed as milliunits/mg protein, where 1 unit of GS activity is the amount of GS that converts 1 µmol L-Glu into product per minute. GS activity detected in wild-type larvae was taken as 100% activity to normalize the values obtained with different larvae batches and in comparison with the values measured with transfected larvae. For each sample, replicates differed by less than 15%.
Immunofluorescences and quantification of the size of Htt-Q93 aggregates
To visualize human mutant Htt-Q93 aggregates, females elav-Gal4; UAS-GFP females were crossed with males carrying the appropriate UAS-transgenes. 
Co-localization analysis
To analyze TOR co-localization with lysosome, females elav-Gal4; UAS-LAMP1-GFP females were crossed with males carrying the appropriate UAS-transgenes. 3 rd larvae were collected, washed and brains were dissected and processed as described above, incubated with anti mTOR antibodies 1:200 overnight at 4°C and processed as above using anti-rabbit secondary antibody Alexa 555 (Invitrogen) at 1:400 in 3% BSA, and then processed as described above. Images were acquired at the confocal 2 0 microscope (SM5 LEICA Leserteknik GmbH) at different magnifications. For each genotype, the acquisition of confocal images were from at least 4 separate brains and the statistics was calculated on 10 z-stacks images/brain. Co-localization of TOR and LAMP1-GFP was quantified using ImageJ 1.50i software using JACoP plugin, Pearson's algorithm with Manders Coefficients and Costes automatic threshold (MCC) [85] .
Statistical analysis
Analysis of the variance was calculated using one-way ANOVA with Tukey multi-comparisons test.
Student t-test analysis between genotypes was performed using GraphPad-PRISM7. One to four asterisk indicate: p* < 0.05, p **< 0.01, p*** < 0.001, p ****< 0.0001, respectively. The * = p < 0.05, ** = p < 0.01, values in panels C were calculated from Student's t-test from at least four independent animals. control w [1118] animals. EEA= essential amino acids, NEA= non-essential amino acids. The * = p < 0.05, ** = p < 0.01, **** = p < 0.0001 values in panels B were calculated from Student's t-test from two independent experiments, error bars indicate the standard deviations. Bibliography:
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